- Filed
- Apr 23, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 638.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 651.7M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 633.65M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1B |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1.9B |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $781M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $732M |
| Capex | Q1 2026 · Mar 31, 2026 | $223M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $190M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$650M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $597M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $32.11B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $28.69B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $4.63B |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $5.89B |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $413M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $443M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $11.98B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $12.49B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $13.59B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $13.9B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $22.09B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $23.41B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $30.59B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $30.39B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $73.99B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $73.68B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.29 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $2.22 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.29 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $2.24 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.31B |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.31B |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $492M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $416M |
| Net Income | Q1 2026 · Mar 31, 2026 | $821M |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.45B |
| Operating Income | Q1 2026 · Mar 31, 2026 | $2.13B |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $2B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $5.6B |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $5.46B |
| Revenue | Q1 2026 · Mar 31, 2026 | $9.14B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $8.93B |